Federated Hermes’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-450,000
Closed -$8.39M 2314
2021
Q4
$8.39M Hold
450,000
0.02% 697
2021
Q3
$12.1M Buy
450,000
+100,000
+29% +$2.75M 0.02% 599
2021
Q2
$10.9M Buy
+350,000
New +$11.1M 0.02% 623

Other funds holding TMCI

Federated Hermes's TMCI Position: Q1 2022 in Review

Federated Hermes sold out of Treace Medical Concepts (TMCI) in Q1 2022, closing a stake of 450,000 shares — an estimated $8.39M sold.

Federated Hermes first reported a position in TMCI in Q2 2021 and held it in 3 quarters. The position peaked at $12.1M in Q3 2021. 75 funds tracked by Wall St. Rank hold TMCI as of Q1 2022.

  • Federated Hermes reported no remaining Treace Medical Concepts position as of Q1 2022 after selling out during the quarter.
  • Federated Hermes sold 450,000 Treace Medical Concepts shares in Q1 2022, an estimated $8.39M.
  • Federated Hermes first reported a position in Treace Medical Concepts in Q2 2021 and held it in 3 quarters.
  • Federated Hermes's Treace Medical Concepts position peaked at $12.1M in Q3 2021.
  • 75 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2022.

Based on Federated Hermes's 13F filing for Q1 2022, filed 13 May 2022.